Skip to main content
Premium Trial:

Request an Annual Quote

JPT Technologies Adopts Arrayjet Arrayer for Peptide Chip Production

Premium

Arrayjet recently installed a customized version of its Ultra Marathon microarrayer instrument at JPT Technologies.

Berlin-based JPT, a subsidiary of BioNTech, will use the Ultra Marathon to print its PepStar peptide microarrays for use in vaccine and immunotherapy development, as well as diagnostics, according to CEO Holger Wenschuh.

Wenshuh said in a statement that the company acquired the high-throughput arrayer, which is capable of printing up to 1,000 slides in a single run, to "comply with large immune monitoring and biomarker discovery projects." He added that the custom instrument meets the "specific challenges of our regulated production environment."

Based in Edinburgh, UK, Arrayjet offers a line of arrayers and services based on its inkjet array printing technology. JPT offers a number of peptide-related services and tools, including high-throughput peptide synthesis and screening, arrays, library assembly, antigen-specific T-cell stimulation, and protein biomarker quantification.

Further details of the deal were not discussed.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.